JAN (NYSE:JAN) Coverage Initiated by Analysts at Mizuho

Equities researchers at Mizuho began coverage on shares of JAN (NYSE:JAN) in a research report issued on Monday, Briefing.com reports. The brokerage set an “outperform” rating and a $33.00 price target on the stock. Mizuho‘s target price would suggest a potential upside of 15.63% from the company’s current price.

A number of other brokerages have also recently commented on JAN. Wells Fargo & Company decreased their price target on JAN from $35.00 to $34.00 and set an “overweight” rating on the stock in a research note on Monday, October 19th. Wall Street Zen upgraded shares of JAN from a “sell” rating to a “hold” rating in a report on Saturday, August 8th. Huntington began coverage on shares of JAN in a research report on Thursday, September 10th. They set an “outperform” rating and a $36.00 price target for the company. Cantor Fitzgerald raised their price target on shares of JAN from $30.00 to $34.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Finally, Weiss Ratings initiated coverage on shares of JAN in a report on Thursday, August 6th. They issued a “hold (c-)” rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, JAN has an average rating of “Moderate Buy” and a consensus target price of $32.35.

JAN Stock Up 0.1%

JAN stock opened at $28.54 on Monday. The firm’s fifty day moving average is $29.68 and its 200 day moving average is $28.02. JAN has a 52 week low of $22.76 and a 52 week high of $32.83.

JAN (NYSE:JAN) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.18). The business had revenue of $216.46 million for the quarter, compared to analyst estimates of $203.32 million. The firm’s revenue for the quarter was up 45.4% compared to the same quarter last year. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. On average, research analysts forecast that JAN will post 0.97 earnings per share for the current fiscal year.

Institutional Investors Weigh In On JAN

Several institutional investors have recently made changes to their positions in the company. Nisa Investment Advisors LLC purchased a new position in shares of JAN in the third quarter worth $27,000. State of Wyoming increased its position in JAN by 258.7% during the third quarter. State of Wyoming now owns 4,814 shares of the company’s stock worth $143,000 after purchasing an additional 3,472 shares during the last quarter. Inspire Investing LLC purchased a new position in shares of JAN during the third quarter worth approximately $484,000. Greenland Capital Management LP purchased a new stake in JAN in the 2nd quarter valued at $575,000. Finally, Sumitomo Mitsui DS Asset Management Company Ltd acquired a new stake in JAN in the 3rd quarter worth about $627,000. Institutional investors own 6.27% of the company’s stock.

About JAN

JanOne Inc (NYSE: JAN) is a social-impact and technology company focused on addressing the opioid crisis. Its activities have included the development and commercialization of solutions intended to support opioid-related treatment and prevention, with an emphasis on using business and technology to promote measurable social benefits.

Through its subsidiaries and related operations, JanOne has also pursued financial technology initiatives, including blockchain-based payment and transaction solutions.